DOCS Stock Analysis: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$20.91
-0.33 (-1.55%)
▼
5d:
+2.4%
30d:
-3.15%
90d:
-14.44%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Smart Money Distribution
None View Scanner →
Strength: 6.1/10
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DOCS trading at deep discount. Market pricing in -10.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: DOCS trading at deep discount. Market pricing in -10.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.98
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$22.34
6.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $20.91, which is considered slightly low relative to its 30-day fair value range of $20.56 to $22.09. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.9) compared to its historical average (17.9). Remarkably, the market is currently pricing in an annual earnings decline of 10.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $20.07, while resistance sits at $21.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.61 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $20.07, while resistance sits at $21.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.61 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$20.56 -
$22.09
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($24.61)
Trading Range Analysis
30-Day Trading Range
$20.56 -
$22.09
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.07
Resistance Level
$21.90
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.90
Wall Street Target
$24.61
(+17.7%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
-69.0%
Profit Margin
30.4%
Valuation Discount vs History
-10.3% cheaper
PE vs Historical
12.9 vs 17.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.3%
(market-implied from PE analysis)
1-Year Target
$18.82
(-10%)
2-Year Target
$16.94
(-19%)
3-Year Target
$15.24
(-27%)
3-Yr Target (if PE normalizes)
(PE: 13→18)
$21.15
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 4.8%)
$38.66
(+85%)
Base:
(SPY PE: 12.9, Growth: 4.8%)
$24.06
(+15%)
Bear:
(PE: 11.0, Growth: 4.8%)
$20.45
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 22.12 | Current EPS (TTM): $0.96
Bull Case
$39.44
(+89%)
Analyst growth 68.8%, PE expands to 24.3
Base Case
$35.86
(+72%)
Market implied 68.8%, PE stable at 22.1
Bear Case
$14.44
(-31%)
Severe decline -20.0%, PE contracts to 18.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.9 to 17.9
Stabilization Target:
$29.01
(+38.7%)
PE Expansion Potential:
+38.7%
Share & Embed Analysis
Last updated: August 02, 2026 10:48 AM ET
Data refreshes hourly during market hours. Next update: 11:48 AM
Data refreshes hourly during market hours. Next update: 11:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram
SELL
2427 shares
2026-04-10
Siddharth Sitaram
SELL
2319 shares
2026-03-10
Kira Scherer Wampler
SELL
2000 shares
2026-03-03
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
Advanced DOCS Option Strategies
Professional options setups generated by AI based on today's DOCS price and gamma walls.
